Hortapharm B.V.
Hortapharm B.V. is a Dutch company that specializes in the research and development of cannabis for medicinal and scientific purposes. Founded in Amsterdam in 1990 by two British horticulturists, David Watson and Robert Clarke, Hortapharm B.V. has been instrumental in the advancement of cannabis genetics and the production of cannabinoids.
History[edit | edit source]
Hortapharm B.V. was established with the aim of creating a legal supply of cannabis for scientific research. The founders, Watson and Clarke, had spent years collecting and breeding cannabis strains from around the world. Their extensive collection of cannabis genetics, known as the Cannabis Seed Bank, became the foundation of Hortapharm's research.
In 1998, Hortapharm B.V. entered into a historic agreement with GW Pharmaceuticals, a British biopharmaceutical company. This partnership allowed GW Pharmaceuticals to access Hortapharm's genetic library for the development of Sativex, the first natural cannabis-based prescription drug.
Research and Development[edit | edit source]
Hortapharm B.V. conducts extensive research into the properties of cannabis and its potential therapeutic uses. The company's research focuses on the development of cannabis strains with specific cannabinoid profiles, which can be used in the treatment of various medical conditions.
Hortapharm's research has contributed significantly to the understanding of the endocannabinoid system, a complex cell-signalling system in the human body that plays a role in regulating a wide range of physiological processes.
Impact and Influence[edit | edit source]
Hortapharm B.V.'s pioneering work in cannabis genetics has had a profound impact on the medical cannabis industry. The company's partnership with GW Pharmaceuticals has led to the development of groundbreaking cannabis-based medicines, including Sativex and Epidiolex, which are used to treat conditions such as multiple sclerosis and epilepsy.
Hortapharm's influence extends beyond the medical field. The company's genetic library has also been used by the United Nations Office on Drugs and Crime (UNODC) for the identification and classification of cannabis strains.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD